bimagrumab and tirzepatide A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass – suggesting a promising approach for Massively disappointing news from @elilillyco

Microbial butyrate production in the human gut has been known for decades (29) before the large sequencing efforts of the gut microbiota started, but it was only in the last decade that metagenomics surveys consistently revealed in multiple independent human cohorts a decrease of butyrate-producing bacteria in individuals with T2D (19, 20)

These results confirmed that semaglutide benefits heart health beyond just diabetes treatment

Tirzepatide is a dual agonist that activates both the GLP-1 receptor and the GIP receptor

Your provider will evaluate your clinical history, monitor your response, and adjust your dosage safely over time to minimize side effects and optimize results

June 24, 2024 : The manufacturer, Teva, launched an authorized generic of Victoza for type 2 diabetes